Scientific Publications Database

Article Title: Randomized phase II study comparing two different schedules of palbociclib plus second line endocrine therapy in women with estrogen receptor positive, HER2 negative advanced/metastatic breast cancer: CCTG MA38 (NCT02630693)
Authors: Parulekar, W. R.; Joy, A. A.; Gelmon, K.; Mates, M.; Desbiens, C.; Clemons, M.; Taylor, S.; Lemieux, J.; Bartlett, J.; Whelan, T.; Ayoub, J-P; Cescon, D.; Bordeleau, L.; Rahim, Y.; Winch, C.; Chen, B. E.
Journal: CANCER RESEARCH Volume 79 Issue 4
Date of Publication:2019
Abstract:
.